Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
21 February 2024 - 12:00AM
Business Wire
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
testing, today announced that it will release results for its
fourth quarter and year ended December 31, 2023, after the market
close on Feb. 28, 2024. Natera will host a conference call and
webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).
Earnings Conference Call Information:
Event:
Natera’s Fourth Quarter and
Year-End 2023 Financial Results
Date:
Wednesday, Feb. 28, 2024
Time:
1:30 p.m. PT (4:30 p.m. ET)
Live Dial-In:
1 (888) 770-7321 (Domestic) 1
(929) 201-7107 (International)
Conference ID:
7684785
Webcast:
https://events.q4inc.com/attendee/656023681
A webcast replay will be available at
investor.natera.com.
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated
to oncology, women’s health, and organ health. We aim to make
personalized genetic testing and diagnostics part of the standard
of care to protect health, and inform earlier, more targeted
interventions that help lead to longer, healthier lives. Natera’s
tests are validated by more than 180 peer-reviewed publications
that demonstrate high accuracy. Natera operates ISO 13485-certified
and CAP-accredited laboratories certified under the Clinical
Laboratory Improvement Amendments (CLIA) in Austin, Texas and San
Carlos, California. For more information, visit www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240220780446/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-405-4709, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Natera (NASDAQ:NTRA)
Historical Stock Chart
From Apr 2024 to May 2024
Natera (NASDAQ:NTRA)
Historical Stock Chart
From May 2023 to May 2024